© 2022 MJH Life Sciences and Endocrinology Network. All rights reserved.
© 2022 MJH Life Sciences™ and Endocrinology Network. All rights reserved.
The last weekend of each month, our editorial team compiles a list of our most popular content from the past month for a month in review recap. The October 2022 month in review recap includes a pair of studies that paint a grim picture related to the burden of diabetes in the US, a trio of new obesity guidelines/reports from major national and international organizations, and news related to the latest developments in the world of continuous glucose monitoring.
Included in our top stories of the month list for October 2022 is a pair of studies describing different aspects of the burden diabetes places on people in the US.
Within a 2-day span from October 20-21, 2022, a trio of articles were published by numerous national and international organizations aimed at providing clinicians with new data and/or recommendations for management of obesity and cooccurring conditions.
Never before have the advancements and advantages provided by diabetes technology been so evident. During the month of October, there were multiple items of note that made headlines related to continuous glucose monitoring technologies, including the global rollout of Dexcom’s G7 CGM system, new flash monitoring data from the FreeStyle Libre 2 system in NEJM, and a joint consensus report from a pair of the world’s largest diabetes organizations.
Related Content: